Plumbagin: A study of its anticancer, antibacterial & antifungal properties.
D000818:Animals; D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000972:Antineoplastic Agents, Phytogenic; D001419:Bacteria / Q000187:drug effects; D004353:Drug Evaluation, Preclinical; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy; D005658:Fungi / Q000187:drug effects; D007942:Leukemia, Experimental / Q000188:drug therapy; D008297:Male; D051379:Mice; D009285:Naphthoquinones / Q000494:pharmacology / Q000627:therapeutic use*; D009374:Neoplasms, Experimental / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000972:Antineoplastic Agents, Phytogenic; D009285:Naphthoquinones; C014758:plumbagin